Matches in Wikidata for { <http://www.wikidata.org/entity/Q94150475> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q94150475 description "article scientifique publié en 2018" @default.
- Q94150475 description "wetenschappelijk artikel" @default.
- Q94150475 description "наукова стаття" @default.
- Q94150475 name "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 name "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 type Item @default.
- Q94150475 label "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 label "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 prefLabel "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 prefLabel "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 P1433 Q94150475-5C066AAF-0C2F-4EB5-B957-04D96FD5300F @default.
- Q94150475 P1476 Q94150475-3E62F3F8-4C54-4904-963B-C170ADE03E7E @default.
- Q94150475 P2093 Q94150475-66BEA14F-C80A-4D40-8B32-B23CB724E716 @default.
- Q94150475 P2093 Q94150475-8696530B-59E3-430F-A477-88F795129849 @default.
- Q94150475 P2093 Q94150475-9B85AACF-18B1-442B-BF16-0010236DF312 @default.
- Q94150475 P2093 Q94150475-BDA89435-9388-438B-92C1-9AC3D069A19C @default.
- Q94150475 P2093 Q94150475-D3035F24-6BDC-49FF-BB29-EF2546752853 @default.
- Q94150475 P304 Q94150475-7A77E072-16E5-4DC3-983D-33377765542F @default.
- Q94150475 P31 Q94150475-55C76312-717E-433E-A98E-5E18A0AE3739 @default.
- Q94150475 P356 Q94150475-0A0BB2EF-FE59-4B6D-90F5-91A329FE83D7 @default.
- Q94150475 P433 Q94150475-D783B790-23C3-4787-900D-F5015812005B @default.
- Q94150475 P478 Q94150475-26CA290A-51B3-4D3C-B86B-F8232ADA595B @default.
- Q94150475 P577 Q94150475-B92144B6-38C2-4585-91EB-1AB5D7CEC9EE @default.
- Q94150475 P921 Q94150475-3BE2D3C5-29C7-452E-865C-2F19A773AEF1 @default.
- Q94150475 P921 Q94150475-FFDF8336-9BFD-4497-8499-CA6A6ABBE95B @default.
- Q94150475 P932 Q94150475-77A7E93C-939B-4A8A-8764-9403682A6611 @default.
- Q94150475 P356 NOY148.1175 @default.
- Q94150475 P1433 Q15724471 @default.
- Q94150475 P1476 "CADD-42. EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR–TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL" @default.
- Q94150475 P2093 "Achuthamangalam Madhankumar" @default.
- Q94150475 P2093 "Becky Sue Webb" @default.
- Q94150475 P2093 "Darya Nesterova" @default.
- Q94150475 P2093 "James Connor" @default.
- Q94150475 P2093 "Oliver Mrowczynski" @default.
- Q94150475 P304 "vi282-vi282" @default.
- Q94150475 P31 Q13442814 @default.
- Q94150475 P356 "10.1093/NEUONC/NOY148.1175" @default.
- Q94150475 P433 "Suppl 6" @default.
- Q94150475 P478 "20" @default.
- Q94150475 P577 "2018-11-05T00:00:00Z" @default.
- Q94150475 P921 Q18936 @default.
- Q94150475 P921 Q233309 @default.
- Q94150475 P932 "6216882" @default.